4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-062271
Chief Dev. & Ops. Officer bought 242 shares at an average $19.44 ($4,704)
From the SEC's structured data for this filing
Trades in this filing
Shemesh Shay · Chief Dev. & Ops. Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-16 | Purchase : show line 1 in the form | +100 | $19.28 | $1,928 | 1,240,993 | D |
| 2022-05-17 | Purchase : show line 2 in the form | +142 | $19.55 | $2,776 | 1,241,135 | D |
| Open-market purchases · 242 sh · avg $19.44 · $4,704 | ||||||
Loading xslF345X03/tm2215754-2_4seq1.xml…